Atlas Trials

Dexmedetomidine Versus Nalbuphine in Prevention of Emergence Agitation Following Adenotonsillectomy in Pediatrics

Clinical trial NCT04058899 · UNKNOWN

Trial details

NCT number
NCT04058899
Sponsor
Ain Shams University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Emergence Delirium
Start date
2019-03-05
Primary completion
2019-09-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.